Modern treatment algorithms improve survival in systemic sclerosis associated pulmonary hypertension
MH Williams, Casilda G. Black, Joseph Davar(The Royal Free Hospital), CE Handler, Colette Smith(MRC Clinical Trials Unit at UCL), Akram, CP Denton(The Royal Free Hospital), Chandan K. Das
UCL Discovery (University College London)
March 1, 2005
Cited by 0
Related Papers
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
|European Journal of Preventive Cardiology|2015|237